Purple Biotech (PPBT) Change in Cash (2017 - 2025)
Purple Biotech has reported Change in Cash over the past 6 years, most recently at $3.9 million for Q4 2022.
- Quarterly Change in Cash rose 117.03% to $3.9 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2022, up 102.73% year-over-year, with the annual reading at $1.3 million for FY2025, 118.48% up from the prior year.
- Change in Cash was $3.9 million for Q4 2022 at Purple Biotech, up from -$2.9 million in the prior quarter.
- Over five years, Change in Cash peaked at $3.9 million in Q4 2022 and troughed at -$51.8 million in Q4 2020.
- The 5-year median for Change in Cash is -$74000.0 (2018), against an average of -$7.0 million.
- Year-over-year, Change in Cash soared 2291.89% in 2019 and then tumbled 3295.01% in 2020.
- A 5-year view of Change in Cash shows it stood at -$74000.0 in 2018, then soared by 2291.89% to $1.6 million in 2019, then tumbled by 3295.01% to -$51.8 million in 2020, then skyrocketed by 103.44% to $1.8 million in 2021, then surged by 117.03% to $3.9 million in 2022.
- Per Business Quant, the three most recent readings for PPBT's Change in Cash are $3.9 million (Q4 2022), -$2.9 million (Q3 2022), and $1.8 million (Q4 2021).